Abstract:Abstract: Objective To explore the relationship between the cognitive function and serum thioredoxin (Trx) and thioredoxin-interacting protein (Txnip) levels, and Trx activity in type 2 diabetic patients, so as to provide new ideas for prevention and treatment of cognitive impairment in these patients. Methods A total of 100 patients with type 2 diabetes mellitus who were hospitalized into Department of Endocrinology, Tangshan Gongren Hospital from 2014 to 2015 were enrolled as case group, at the same time, 90 healthy people were selected as control group. Demographic data (age, gender, education level, BMI, duration of disease, etc.) and clinical biochemical indicators (FPG, HbA1c, TC, TG, HDL and LDL) of all the research objects were collected. The cognitive function scale (RBANS) (including immediate memory, vision span, speech function, attention and delayed memory) scores were evaluated. The serum Trx and Txnip levels were detected by ELISA, the activity of Trx was tested by insulin reduction assay. Results Compared with the control group, FPG, HbA1C, TG, Trx and Txnip levels increased in the case group (P < 0.05), but Trx activity decreased in the case group (P < 0.05). Compared with the control group, RBANS scores including immediate memory, delayed memory and total scores were lowered in the T2DM patients (P < 0.05). In the case group, the serum Trx and Txnip levels were positively associated with fasting blood glucose and glycosylated hemoglobin (P < 0.05), the activity of Trx was negatively correlated with the level of Txnip (P < 0.05). The serum Trx and Txnip levels were negatively correlated with and the activity of Trx was positively correlated with the total RBANS scale score and the delayed memory score (P < 0.05). Conclusions The increased serum Trx and Txnip and decreased Trx activity may be risk factors for cognitive dysfunction in patients with type 2 diabetes mellitus.